chr14-104701630-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_022489.4(INF2):c.265G>A(p.Val89Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000069 in 1,449,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022489.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease dominant intermediate EInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- focal segmental glomerulosclerosis 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022489.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| INF2 | NM_022489.4 | MANE Select | c.265G>A | p.Val89Ile | missense | Exon 2 of 23 | NP_071934.3 | ||
| INF2 | NM_001426862.1 | c.265G>A | p.Val89Ile | missense | Exon 2 of 23 | NP_001413791.1 | |||
| INF2 | NM_001426863.1 | c.265G>A | p.Val89Ile | missense | Exon 2 of 23 | NP_001413792.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| INF2 | ENST00000392634.9 | TSL:5 MANE Select | c.265G>A | p.Val89Ile | missense | Exon 2 of 23 | ENSP00000376410.4 | ||
| INF2 | ENST00000398337.8 | TSL:1 | c.265G>A | p.Val89Ile | missense | Exon 2 of 5 | ENSP00000381380.4 | ||
| INF2 | ENST00000617571.5 | TSL:1 | n.265G>A | non_coding_transcript_exon | Exon 1 of 22 | ENSP00000483829.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00000441 AC: 1AN: 226538 AF XY: 0.00000798 show subpopulations
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1449116Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 720394 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Uncertain:1
This sequence change replaces valine with isoleucine at codon 89 of the INF2 protein (p.Val89Ile). The valine residue is moderately conserved and there is a small physicochemical difference between valine and isoleucine. This variant is present in population databases (rs765566674, ExAC 0.002%). This variant has not been reported in the literature in individuals with INF2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at